Parallel Advisors’s Biomerica BMRA Stock Holding History

Parallel Advisors’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-56	Closed	-$2K	–	2941
2021 Q1	$2K	Buy	+56	New	+$2.87K	﹤0.01%	2444

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fore Capital New York $162M AUM 14.69% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Parallel Advisors's BMRA Position: Q2 2021 in Review

Parallel Advisors sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 56 shares — an estimated $2K sold.

Parallel Advisors first reported a position in BMRA in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

Parallel Advisors reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
Parallel Advisors sold 56 Biomerica shares in Q2 2021, an estimated $2K.
Parallel Advisors first reported a position in Biomerica in Q1 2021 and held it in 1 quarter.
Parallel Advisors's Biomerica position peaked at $2K in Q1 2021.
26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Parallel Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.